DOI QR코드

DOI QR Code

Mexican Breast Cancer Research Output, 2003-2012

  • Perez-Santos, Jose Luis Martin (Vice-rectory of Research and Postgraduate Studies, Benemerita Universidad Autonoma de Puebla) ;
  • Anaya-Ruiz, Maricruz (Laboratory of Cellular Biology, Centro de Investigacion Biomedica de Oriente, Instituto Mexicano del Seguro Social)
  • Published : 2013.10.30

Abstract

The objetive of this study was to explore a bibliometric approach to quantitatively assess current research trends with regard to breast cancer in Mexico. Articles were analyzed by scientific output and research performances of individuals, institutes, and collaborative countries with Mexico. Data were retrieved from the Web of Science database from 2003 to 2012; this was searched using different terms related to breast cancer, including "breast cancer", "mammary ductal carcinoma" and "breast tumour". Data were then extracted from each file, transferred to Excel charts and visualised as diagrams. A total of 256 articles were retrieved. The institutions with the majority of publications were the National Autonomous University of Mexico (22.3%), the National Institute of Cancerology (21.9%), and Social Security Mexican Institute (20.3%); clinical observation studies were the dominant investigation type (64%), and the main types of research were metabolics (24.2%) and pathology (21.5%). This article demonstrates the usefulness of bibliometrics to address key evaluation questions and to establish priorities, define future areas of research, and develop breast cancer control strategies in Mexico.

Keywords

References

  1. Calo WA, Suarez-Balseiro C, Suarez E, et al (2010). Assessing the scientific research productivity of Puerto Rican cancer researchers: bibliometric analysis from the science citation index. Puerto Rico Health Sci J, 29, 250-5.
  2. Campbell D, Picard-Aitken M, Cote G, et al (2010). Bibliometrics as a performance measurement tool for research evaluation: The case of research funded by the National Cancer Institute of Canada. Am J Evaluation, 31, 66-83. https://doi.org/10.1177/1098214009354774
  3. Chavarri-Guerra Y, Villarreal-Garza C, Liedke P, et al (2012). Breast cancer in Mexico: a growing challenge to health and the health system. Lancet Oncol, 13, 335-46. https://doi.org/10.1016/S1470-2045(12)70246-2
  4. de la Vara-Salazar E, Suarez-Lopez L, Angeles-Llerenas A, et al (2011). Breast cancer mortality trends in Mexico, 1980-2009. Salud Publica Mex, 53, 385-93. https://doi.org/10.1590/S0036-36342011000500006
  5. Donato HM, De Oliveira CF (2006). Breast pathology: evaluation of the Portuguese scientific activity based on bibliometric indicators. Acta Medica Portuguesa, 19, 225-34.
  6. El-Basmy A, Al-Mohannadi S, Al-Awadi A (2012). Some epidemiological measures of cancer in Kuwait: national cancer registry data from 2000-2009. Asian Pac J Cancer Prev, 13, 3113-8. https://doi.org/10.7314/APJCP.2012.13.7.3113
  7. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al., (2013). Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer, 49, 1374-1403. https://doi.org/10.1016/j.ejca.2012.12.027
  8. Glynn RW, Scutaru C, Kerin MJ, Sweeney KJ (2010). Breast cancer research output, 1945-2008: a bibliometric and density-equalizing analysis. Breast Cancer Res, 12, 108. https://doi.org/10.1186/bcr2569
  9. Gonzalez-Robledo LM, Gonzalez-Robledo MC, Nigenda G, et al. (2010). Government actions for the early detection of breast cancer in Latin America. Salud Publica Mex, 52, 533-43. https://doi.org/10.1590/S0036-36342010000600009
  10. Haghighat S, Akbari M, Ghaffari S (2012). Standardized breast cancer mortality rate compared to the general female population of Iran. Asian Pac J Cancer Prev, 13, 5525-8. https://doi.org/10.7314/APJCP.2012.13.11.5525
  11. Healy NA, Glynn RW, Scutaru C, et al (2011). The h index and the identification of global benchmarks for breast cancer research output. Breast Cancer Res Treatment, 127, 845-51. https://doi.org/10.1007/s10549-011-1436-z
  12. Ho Y-S, Satoh H, Lin S-Y (2010). Japanese lung cancer research trends and performance in science citation index. Int Med, 49, 2219-28. https://doi.org/10.2169/internalmedicine.49.3687
  13. Justo N, Wilking N, Jonsson B, et al (2013). A review of breast cancer care and outcomes in Latin America. Oncologist, 18, 248-56. https://doi.org/10.1634/theoncologist.2012-0373
  14. Kutikhin AG, Yuzhalin AE, Brailovskiy VV, et al (2012). Analysis of cancer incidence and mortality in the industrial region of South-East Siberia from 1991 through 2010. Asian Pac J Cancer Prev, 13, 5189-93. https://doi.org/10.7314/APJCP.2012.13.10.5189
  15. Pandey S, Chandravati (2013). Breast screening in north India: a cost-effective cancer prevention strategy. Asian Pac J Cancer Prev, 14, 853-7. https://doi.org/10.7314/APJCP.2013.14.2.853
  16. Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29. https://doi.org/10.3322/caac.20138

Cited by

  1. A Bibliometric Analysis of Diets and Breast Cancer Research vol.15, pp.18, 2014, https://doi.org/10.7314/APJCP.2014.15.18.7625
  2. Cervical Cancer Trends in Mexico: Incidence, Mortality and Research Output vol.15, pp.20, 2014, https://doi.org/10.7314/APJCP.2014.15.20.8689
  3. Contribution of Arab countries to breast cancer research: comparison with non-Arab Middle Eastern countries vol.15, pp.1, 2015, https://doi.org/10.1186/s12905-015-0184-3
  4. Innovation Status of Gene Therapy for Breast Cancer vol.16, pp.9, 2015, https://doi.org/10.7314/APJCP.2015.16.9.4133
  5. Association of Histopathological Markers with Clinico-Pathological Factors in Mexican Women with Breast Cancer vol.16, pp.18, 2016, https://doi.org/10.7314/APJCP.2015.16.18.8397
  6. Neural Transdifferentiation: MAPTau Gene Expression in Breast Cancer Cells vol.17, pp.4, 2016, https://doi.org/10.7314/APJCP.2016.17.4.1967